Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Absence of cardiodepressive effects with beraprost

July 13, 1998

Cor Therapeutics patents novel factor Xa inhibitors

July 9, 1998

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

July 9, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

Platelet aggregation inhibitors in development at Meiji Seika

July 6, 1998

FDA advisory committee to review Pletal NDA next week

July 3, 1998

Zeria discloses new thromboxane antagonists for thrombosis

July 3, 1998

HMR introduces Refludan in U.S.

July 2, 1998

Factor Xa inhibitors developed by Boehringer Mannheim researchers

June 30, 1998

RPR acquires worldwide rights to Novartis anticoagulant

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....